Inglés

Concomitant Medications study Dyskinesia in Parkinson's disease NCT00363727

1 formularios  
General information
Descripción

General information

Protocol indentifier
Descripción

Protocol indentifier

Tipo de datos

text

Subject Identifier
Descripción

Subject Identifier

Tipo de datos

text

Alias
UMLS CUI [1]
C2348585
Visit date
Descripción

Visit date

Tipo de datos

date

Visit Description
Descripción

Visit Description

Tipo de datos

text

Concomitant medication
Descripción

Concomitant medication

Concomitant medication
Descripción

Record any changes to the subject's concomitant medications or any new medications taken since the last visit in the appropriate Concomitant Medications section.

Tipo de datos

text

L-Dopa medication changes
Descripción

L-Dopa medication changes

Has there been any change in dose or frequency of L-Dopa medication since the last visit?
Descripción

Note: Record any changes to the subject's L-Oopa medication taken since the last visit in the L-Dopa Medication section and contact GSK

Tipo de datos

boolean

Parkinson's Disease Symptom Control
Descripción

Parkinson's Disease Symptom Control

Does the subject experience a reduction in Parkinson's Disease symptom control within 4 hours of the dose of L-dopa?
Descripción

Parkinson's Disease Symptom Control

Tipo de datos

boolean

Volver a la parte superior de la página

Similar models

Concomitant Medications study Dyskinesia in Parkinson's disease NCT00363727

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
General information
Protocol indentifier
Item
Protocol indentifier
text
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Visit date
Item
Visit date
date
Visit Description
Item
Visit Description
text
Item Group
Concomitant medication
Concomitant medication
Item
Concomitant medication
text
Item Group
L-Dopa medication changes
change of L-Dopa medication
Item
Has there been any change in dose or frequency of L-Dopa medication since the last visit?
boolean
Item Group
Parkinson's Disease Symptom Control
Parkinson's Disease Symptom Control
Item
Does the subject experience a reduction in Parkinson's Disease symptom control within 4 hours of the dose of L-dopa?
boolean
Volver a la parte superior de la página